Publications

Search our bibliography using the filters on the right-hand side.

Displaying 51 through 54 of 54 publications.

Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Wolf MK. What is a clinically meaningful change (CMC) on the functional assessment of cancer therapy - lung (FACT-L): analysis of ecog 5592 data. Poster presented at the 37th Annual Meeting of the American Society of Clinical Oncology; May 2001. San Francisco, CA.

Leidy NK, Jonas D, Margolis MK, Heyes AE, Jones K, Silberman C. On health-related quality of life, symptoms and the complementary nature of two patient-reported outcomes. Presented at the Drug Information Association Symposium of Contributed Papers on Quality of Life Evaluation; March 2001. Hilton Head, SC.

Cella D, Eton DT, Fairclough DL, Heyes AE, Silberman C, Bonomi P, Wolf MK. What is a clinically meaningful change (CMC) on the Functional Assessment of Cancer Therapy (lung) (FACT-L): analysis of ECOG 5592 data. Lung Cancer. 2001;373-6.

Sculpher M, Palmer MK, Heyes AE. Costs incurred by patients undergoing advanced colorectal cancer therapy. A comparison of raltitrexed and fluorouracil plus folinic acid. Pharmacoeconomics. 2000 Apr;17(4):361-70.